The US pharmaceutical company Eli Lilly has met with the Department of Enterprise to express concerns about planned changes to the patent law in Europe. The multinational, which employs 3,500 people ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its ...

Eli Lilly and Company today announced its financial results for the third-quarter of 2025. "Lilly delivered another strong quarter, with 54% revenue growth year-over-year driven by continued demand ...

The Hollywood star sat down with Newsweek to discuss his next big project: upping enrollment in clinical trials.

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ -- ...

Basketball legend, entrepreneur and entertainer Shaquille O'Neal partners with Lilly to shine a spotlight on moderate-to-severe obstructive sleep apnea (OSA), encouraging ...

New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

Eli Lilly and Company today announced its roster of Team USA athletes for the Olympic and Paralympic Winter Games Milano Cortina 2026, reaffirming its mission to support athletes' holistic health and ...

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2025 of $1.50 ...